160 related articles for article (PubMed ID: 35647402)
41. Primary tumor necrosis predicts distant control in locally advanced soft-tissue sarcomas after preoperative concurrent chemoradiotherapy.
MacDermed DM; Miller LL; Peabody TD; Simon MA; Luu HH; Haydon RC; Montag AG; Undevia SD; Connell PP
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1147-53. PubMed ID: 19577863
[TBL] [Abstract][Full Text] [Related]
42. The treatment of high-grade soft tissue sarcomas with preoperative thermoradiotherapy.
Prosnitz LR; Maguire P; Anderson JM; Scully SP; Harrelson JM; Jones EL; Dewhirst M; Samulski TV; Powers BE; Rosner GL; Dodge RK; Layfield L; Clough R; Brizel DM
Int J Radiat Oncol Biol Phys; 1999 Nov; 45(4):941-9. PubMed ID: 10571201
[TBL] [Abstract][Full Text] [Related]
43. Cisplatin/etoposide chemotherapy combined with twice daily thoracic radiotherapy for limited small-cell lung cancer: a clinical phase II trial.
Chen GY; Jiang GL; Wang LJ; Qian H; Fu XL; Yang H; Wu KL; Zhao S
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):70-5. PubMed ID: 15629596
[TBL] [Abstract][Full Text] [Related]
44. Phase I trial of preoperative doxorubicin-based concurrent chemoradiation and surgical resection for localized extremity and body wall soft tissue sarcomas.
Pisters PW; Patel SR; Prieto VG; Thall PF; Lewis VO; Feig BW; Hunt KK; Yasko AW; Lin PP; Jacobson MG; Burgess MA; Pollock RE; Zagars GK; Benjamin RS; Ballo MT
J Clin Oncol; 2004 Aug; 22(16):3375-80. PubMed ID: 15310783
[TBL] [Abstract][Full Text] [Related]
45. Locally advanced rectal carcinoma: preoperative radiotherapy versus postoperative chemoradiation, 10-year follow-up results of a randomized clinical study.
Taher AN; El-Baradie MM; Nasr AM; Khorshid O; Morsi A; Hamza MR; Mokhtar N; Ezzat S
J Egypt Natl Canc Inst; 2006 Sep; 18(3):233-43. PubMed ID: 17671533
[TBL] [Abstract][Full Text] [Related]
46. Randomized phase III study comparing conventional-dose doxorubicin plus ifosfamide versus high-dose doxorubicin plus ifosfamide plus recombinant human granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: A trial of the European Organization for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma Group.
Le Cesne A; Judson I; Crowther D; Rodenhuis S; Keizer HJ; Van Hoesel Q; Blay JY; Frisch J; Van Glabbeke M; Hermans C; Van Oosterom A; Tursz T; Verweij J
J Clin Oncol; 2000 Jul; 18(14):2676-84. PubMed ID: 10894866
[TBL] [Abstract][Full Text] [Related]
47. [Complications and short-term outcomes of intraoperative electron radiotherapy (IOERT) in patients with periarticular soft-tissue sarcomas of the extremities].
Fan CC; Feng QF; Zhai YR; Li MH; Xu LB; Zhao ZG; Chen XY; Hu ZH; Zhang YQ; Yu SJ
Zhonghua Zhong Liu Za Zhi; 2012 Apr; 34(4):311-5. PubMed ID: 22781047
[TBL] [Abstract][Full Text] [Related]
48. Preoperative multidisciplinary treatment with hyperthermia for soft tissue sarcoma.
Makihata E; Kuroda M; Kawai A; Ozaki T; Sugihara S; Inoue H; Joja I; Asaumi J; Kawasaki S; Hiraki Y
Acta Med Okayama; 1997 Apr; 51(2):93-9. PubMed ID: 9142346
[TBL] [Abstract][Full Text] [Related]
49. Intensity modulated radiation therapy and surgery for Management of Retroperitoneal Sarcomas: a single-institution experience.
Cosper PF; Olsen J; DeWees T; Van Tine BA; Hawkins W; Michalski J; Zoberi I
Radiat Oncol; 2017 Dec; 12(1):198. PubMed ID: 29216884
[TBL] [Abstract][Full Text] [Related]
50. Hypofractionated Image-guided Radiation Therapy (3Gy/fraction) in Patients Affected by Inoperable Advanced-stage Non-small Cell Lung Cancer After Long-term Follow-up.
Agolli L; Valeriani M; Bracci S; Nicosia L; DE Sanctis V; Enrici RM; Osti MF
Anticancer Res; 2015 Oct; 35(10):5693-700. PubMed ID: 26408745
[TBL] [Abstract][Full Text] [Related]
51. The effect of delayed postoperative irradiation on local control of soft tissue sarcomas of the extremity and torso.
Schwartz DL; Einck J; Hunt K; Bruckner J; Conrad E; Koh WJ; Laramore GE
Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1352-9. PubMed ID: 11955749
[TBL] [Abstract][Full Text] [Related]
52. Escalated hyperfractionated accelerated radiation therapy for locally advanced non-small cell lung cancer: a clinical phase II trial.
Chen GY; Jiang GL; Qian H; Wang LJ; Yang HJ; Fu XL; Wu KL; Zang Z; Zhao S
Radiother Oncol; 2004 May; 71(2):157-62. PubMed ID: 15110448
[TBL] [Abstract][Full Text] [Related]
53. Dose escalation of accelerated hypofractionated three-dimensional conformal radiotherapy (at 3 Gy/fraction) with concurrent vinorelbine and carboplatin chemotherapy in unresectable stage III non-small-cell lung cancer: a phase I trial.
Lin Q; Liu YE; Ren XC; Wang N; Chen XJ; Wang DY; Zong J; Peng Y; Guo ZJ; Hu J
Radiat Oncol; 2013 Aug; 8(1):201. PubMed ID: 23957889
[TBL] [Abstract][Full Text] [Related]
54. Phase I-II study of hypofractionated simultaneous integrated boost using volumetric modulated arc therapy for adjuvant radiation therapy in breast cancer patients: a report of feasibility and early toxicity results in the first 50 treatments.
Scorsetti M; Alongi F; Fogliata A; Pentimalli S; Navarria P; Lobefalo F; Garcia-Etienne C; Clivio A; Cozzi L; Mancosu P; Nicolini G; Vanetti E; Eboli M; Rossetti C; Rubino A; Sagona A; Arcangeli S; Gatzemeier W; Masci G; Torrisi R; Testori A; Alloisio M; Santoro A; Tinterri C
Radiat Oncol; 2012 Aug; 7():145. PubMed ID: 22929062
[TBL] [Abstract][Full Text] [Related]
55. Effect of Neoadjuvant Chemotherapy Plus Regional Hyperthermia on Long-term Outcomes Among Patients With Localized High-Risk Soft Tissue Sarcoma: The EORTC 62961-ESHO 95 Randomized Clinical Trial.
Issels RD; Lindner LH; Verweij J; Wessalowski R; Reichardt P; Wust P; Ghadjar P; Hohenberger P; Angele M; Salat C; Vujaskovic Z; Daugaard S; Mella O; Mansmann U; Dürr HR; Knösel T; Abdel-Rahman S; Schmidt M; Hiddemann W; Jauch KW; Belka C; Gronchi A;
JAMA Oncol; 2018 Apr; 4(4):483-492. PubMed ID: 29450452
[TBL] [Abstract][Full Text] [Related]
56. Significant Reduction of Late Toxicities in Patients With Extremity Sarcoma Treated With Image-Guided Radiation Therapy to a Reduced Target Volume: Results of Radiation Therapy Oncology Group RTOG-0630 Trial.
Wang D; Zhang Q; Eisenberg BL; Kane JM; Li XA; Lucas D; Petersen IA; DeLaney TF; Freeman CR; Finkelstein SE; Hitchcock YJ; Bedi M; Singh AK; Dundas G; Kirsch DG
J Clin Oncol; 2015 Jul; 33(20):2231-8. PubMed ID: 25667281
[TBL] [Abstract][Full Text] [Related]
57. The role of radiation therapy in treatment of adults with newly diagnosed glioblastoma multiforme: a systematic review and evidence-based clinical practice guideline update.
Ziu M; Kim BYS; Jiang W; Ryken T; Olson JJ
J Neurooncol; 2020 Nov; 150(2):215-267. PubMed ID: 33215344
[TBL] [Abstract][Full Text] [Related]
58. Neoadjuvant Interdigitated Chemoradiotherapy Using Mesna, Doxorubicin, and Ifosfamide for Large, High-grade, Soft Tissue Sarcomas of the Extremity: Improved Efficacy and Reduced Toxicity.
Chowdhary M; Sen N; Jeans EB; Miller L; Batus M; Gitelis S; Wang D; Abrams RA
Am J Clin Oncol; 2019 Jan; 42(1):1-5. PubMed ID: 29782358
[TBL] [Abstract][Full Text] [Related]
59. A phase II study evaluating neo-/adjuvant EIA chemotherapy, surgical resection and radiotherapy in high-risk soft tissue sarcoma.
Schmitt T; Lehner B; Kasper B; Bischof M; Roeder F; Dietrich S; Dimitrakopoulou-Strauss A; Strauss LG; Mechtersheimer G; Wuchter P; Ho AD; Egerer G
BMC Cancer; 2011 Dec; 11():510. PubMed ID: 22152120
[TBL] [Abstract][Full Text] [Related]
60. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
